Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Norris

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neckM R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Docetaxel: an active drug for squamous cell carcinoma of the head and neckA I Dreyfuss, J R Clark, C M Norris, et al.
Seminars in Oncology|June 1, 1988
Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancerJ R Clark, B G Fallon, A I Dreyfuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neckT J Ervin, J R Clark, R R Weichselbaum, et al.
American Journal of Clinical Oncology|April 11, 2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)A D Colevas, C M Norris, R B Tishler, et al.
Neurochemical Research|March 25, 2018
Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC CurrentsH N Frazier, K L Anderson, S Maimaiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neckA D Colevas, C M Norris, R B Tishler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trialA D Colevas, P M Busse, C M Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term resultsJ R Clark, P M Busse, C M Norris, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neckM R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Docetaxel: an active drug for squamous cell carcinoma of the head and neckA I Dreyfuss, J R Clark, C M Norris, et al.
Seminars in Oncology|June 1, 1988
Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancerJ R Clark, B G Fallon, A I Dreyfuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neckT J Ervin, J R Clark, R R Weichselbaum, et al.
American Journal of Clinical Oncology|April 11, 2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)A D Colevas, C M Norris, R B Tishler, et al.
Neurochemical Research|March 25, 2018
Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC CurrentsH N Frazier, K L Anderson, S Maimaiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neckA D Colevas, C M Norris, R B Tishler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trialA D Colevas, P M Busse, C M Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term resultsJ R Clark, P M Busse, C M Norris, et al.
Pageof 10